<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00156039</url>
  </required_header>
  <id_info>
    <org_study_id>OCOG-1997-FUP</org_study_id>
    <secondary_id>CBCRI-grant-010413</secondary_id>
    <nct_id>NCT00156039</nct_id>
  </id_info>
  <brief_title>Randomized Trial of Follow-up Strategies in Breast Cancer</brief_title>
  <official_title>A Randomized Trial of Follow-up Strategies in Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ontario Clinical Oncology Group (OCOG)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Breast Cancer Initiative</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ontario Clinical Oncology Group (OCOG)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether family physician 'routine follow-up care'
      of women with breast cancer in remission is an acceptable alternative to the existing system
      of specialist follow-up. Primary outcome measure are event rates of oncological catastrophes
      and quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      see above
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 1997</start_date>
  <completion_date type="Actual">June 2003</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of clinically catastrophic events</measure>
    <time_frame>Up to 5 yrs after randomization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of Karnofsky performance status &lt; 70</measure>
    <time_frame>Up to 5 yrs after randomization</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychosocial well being of patients in remission</measure>
    <time_frame>Up to 5 yrs after randomization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life after recurrence</measure>
    <time_frame>Up to 5 yrs after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>Up to 5 yrs after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Economic evaluation</measure>
    <time_frame>Up to 5 yrs after randomization</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">968</enrollment>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Follow-up Strategy for Breast Cancer</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with breast cancer on well follow-up at regional cancer centres in Ontario and
             Manitoba

          -  Diagnosed at least 12 months previously (range 9-15 months)

          -  Without evidence of active disease (i.e., stages IIIB and IV excluded)

          -  Free from any primary treatment complications

        Exclusion Criteria:

          -  Primary treatment at least 3 months previously, except for continued use of tamoxifen

          -  Still experiencing complications of primary treatment (patients will become eligible
             once complications resolve provided they are within the 6 month window)

          -  Unable to identify an acceptable family physician to provide follow-up

          -  Language or literacy skills inconsistent with completing questionnaires

          -  Unable to comply with study protocol including completion of questionnaires

          -  Previously enrolled in a study which requires continued follow-up in specialist or
             peripheral clinics

          -  Actively followed at a cancer centre for another primary cancer
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Grunfeld, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Cancer Care Nova Scotia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Levine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ontario Clinical Oncology Group (OCOG)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Juravinski Cancer Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8V 5C2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kingston Regional Cancer Centre</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7M 4J2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ottawa Hospital - Integrate Cancer Program</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thunder Bay Regional Health Sciences Centre</name>
      <address>
        <city>Thunder Bay</city>
        <state>Ontario</state>
        <zip>P7B 6V4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toronto Sunnybrook Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, Verma S, Dent S, Sawka C, Pritchard KI, Ginsburg D, Wood M, Whelan T. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006 Feb 20;24(6):848-55. Epub 2006 Jan 17.</citation>
    <PMID>16418496</PMID>
  </results_reference>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>July 24, 2009</last_update_submitted>
  <last_update_submitted_qc>July 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Eva Grunfeld</name_title>
    <organization>Cancer Outcomes Research</organization>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>Follow-up Strategy</keyword>
  <keyword>Follow-up Care</keyword>
  <keyword>Family Physician</keyword>
  <keyword>Oncologist</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

